California Shale Rush - Buy THIS Stock Now!

Forward to a Friend Having trouble viewing this issue? Click here. Refer a Friend to Energy and Capital.

California Shale Rush - Buy THIS Stock Now! By Jeff Siegel | Monday, June 10th, 2013 Quite frankly, I think the whole thing is being blown out of proportion. I'm referring to the notion that some great Arctic oil rush will open up the floodgates and usher in a new era of cheap and abundant oil. First of all, it's not going to be cheap. Arctic oil production is prohibitively expensive (right now, anyway), and I wouldn't put too much faith in bold claims of abundance and never-ending prosperity. Don't get me wrong; roughly 13% of the world's undiscovered oil and 30% of its natural gas can be found beneath the icy waters of the Arctic. And over the long term, production costs will make sense. This is why so many major oil players are laying the groundwork now for Arctic production. In fact, just last week we learned that Russia, Norway, and Finland are looking to create an investment fund designed to provide the capital necessary to tap billions of barrels of oil and natural gas. And it looks like OAO Gazprom, Statoil ASA (NYSE: STO) and Total SA (NYSE: TOT) could be among the biggest beneficiaries of this fund. But there's much more to this story... Advertisement Radical Technology Promises to Break Big Pharma Profit Records One small company's "sea snail" technology will soon be the global Gold Standard for the treatment and prevention of major cancers, autoimmune, and infectious diseases. It's expected to save millions of lives — and bring over 30,000% returns to investors of this medical miracle. Click here to earn 300 times your money. California Will Get Fracked While the Norwegians and the Russians continue to dig deep into the salty ice for access to a wealth of Arctic oil, the U.S. has, for the most part, thrown up its hands. Sure, Exxon (NYSE: XOM), and other U.S. companies will seek access to some of those Russian parcels. But for the most part, American producers know that right now, the gettin's good in shale — not ice. And no matter where you go in the country, the shale boom continues. Heck, just last week California lawmakers balked at pushing a bill that would ban fracking in the Golden State. Despite objections from residents and environmentalists, there's little doubt that California's about to get fracked. After all, we're looking at a potential 15.4 billion barrels in the Monterey Shale alone. That's about 60% of the nation's shale oil reserves. Lawmakers know with that much oil sitting below their feet, they will have little trouble raising revenue in a state that has had its fair share of economic woes. Of course, progress isn't going to happen overnight. And while my colleague Keith Kohl is actively developing new ways for you to play the Monterey Shale, there's another goldmine in California that can deliver some pretty fat profits in the near term... Advertisement Massive Shale Discovery in Kiwi Nation — You must act today! I've found a tiny sub-$1 company in New Zealand sitting on one of the largest shale reserves in the world. Along with another small company, they control over 5,000 square miles of the most oil rich land in the world. There's so much oil there... it's literally leaking to the surface. You've got to hurry on this one, word is starting to get out — and drilling has already started. Learn all the exciting details here.  $710 Million California Payday This one isn't actually an energy play, but rather a backdoor biotech play. You see, not many people know this, but there are hundreds of different drugs in the marketplace that rely on a steady supply of a special compound called Keyhole Limpet Hemocyanin (KLH). This compound can be found in a range of drugs treating everything from cancer to Alzheimer's to Crohn's disease. But there's a problem. This particular compound only comes from one place: the blood of a certain type of sea snail that can only be found off the coast of California. And apparently, there are only about 100,000 of these sea snails left. Once they're gone, they're gone. And along with their extinction comes the extinction of all those drugs that need KLH to work. Of course, there's a boatload of cash to be made in KLH. We're talking as much as $900,000 per gram! So it's no surprise that with this potential crisis comes a massive opportunity... Now, while KLH is too big and complicated to successfully synthesize, there is a way to extract KLH from these sea snails without the animals dying. In fact, they can even continue to live for up to 35 years. And one company, dear reader, has the only patent on this process. Based out of California, this $0.60 tech play has already signed agreements with seven of the 15 largest pharmaceutical companies in the world — and is now sitting on a potential $710 million in annual revenue. You can take a closer look at the numbers here. Although I'm primarily an energy guy, this is an opportunity that I have not ignored. In fact, for the sake of full disclosure, I took a position in the company earlier this year. It's just one of those rare finds that's too mouthwatering to pass up... Even if you're not into biotechs, I strongly recommend just taking a few moments to look at some of the technicals on this one, as this is probably some of the easiest money we'll make all year. To a new way of life and a new generation of wealth... Jeff Siegel @JeffSiegel on Twitter Jeff is the managing editor of Energy and Capital and contributing analyst for the Energy Investor, an independent investment research service focusing primarily on stocks in the oil & gas, modern energy and infrastructure markets.  He has been a featured guest on Fox, CNBC, and Bloomberg Asia, and is the author of the best-selling book, Investing in Renewable Energy: Making Money on Green Chip Stocks. For more on Jeff, go to his editor's page.   I liked this article | I did not like this article Follow Energy and Capital on The Bottom Line Related Articles California Fracking Investing Fukushima Nuclear Investing Solar Failures Rising Recently... Natty Gas: Putting the Fun in Fungible These Solar Panels Do NOT Work! The U.S. Gov't Just Doesn't Get It Fukushima Strikes Again! A $46.2 Billion Payday

This email was sent to ignoble.experiment@arconati.us . You can manage your subscription and get our privacy policy here. Energy and Capital, Copyright © 2013, Angel Publishing LLC, 1012 Morton St, Baltimore, MD 21201. All rights reserved. No statement or expression of opinion, or any other matter herein, directly or indirectly, is an offer or the solicitation of an offer to buy or sell the securities or financial instruments mentioned. While we believe the sources of information to be reliable, we in no way represent or guarantee the accuracy of the statements made herein. Energy and Capital does not provide individual investment counseling, act as an investment advisor, or individually advocate the purchase or sale of any security or investment. Neither the publisher nor the editors are registered investment advisors. Subscribers should not view this publication as offering personalized legal or investment counseling. Investments recommended in this publication should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company in question. Unauthorized reproduction of this newsletter or its contents by Xerography, facsimile, or any other means is illegal and punishable by law. Please note: It is not our intention to send email to anyone who doesn't want it. If you're not sure why you're getting this e-letter, or no longer wish to receive it, get more info here, including our privacy policy and information on how to manage your subscription.